Clinical Trial Update: BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study evaluating BAFF CAR-T cells (LMY-920) for systemic lupus erythematosus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BAFF CAR-T Cells (LMY-920)

Snippet

Sponsor: Luminary Therapeutics | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING